Showing results (331-340 of 346) with videos related to

Sort By:
Pageof 35
Schizophrenia Bulletin|May 17, 2001
Three strategies for changing attributions about severe mental illnessP W Corrigan, L P River, R K Lundin, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|August 30, 2011
Household transmission of haemolytic uraemic syndrome associated with Escherichia coli O104:H4, south-western France, June 2011B Aldabe, Y Delmas, G Gault, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 8, 2024
Microbial metabolism disrupts cytokine activity to impact host immune responseEleanor K P Marshall, Catarina Nunes, Sophie Burbaud, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 24, 1997
Impaired fertility in mice deficient for the testicular germ-cell protease PC4M Mbikay, H Tadros, N Ishida, et al.
British Journal of Cancer|July 7, 2017
Integrating cytokines and angiogenic factors and tumour bulk with selected clinical criteria improves determination of prognosis in advanced renal cell carcinomaA J Zurita, R C Gagnon, Y Liu, et al.
American Journal of Clinical Pathology|December 10, 1999
Do proficiency test results correlate with the work performance of screeners who screen Papanicolaou smears?R A Keenlyside, C L Collins, J S Hancock, et al.
The Journal of Hospital Infection|November 20, 2025
Comparison of two models of biofilm formation on reusable stainless steel medical device materialG G Anderson, S James, S Kovvali, et al.
Preventing Chronic Disease|May 13, 2005
Prevention Research Centers: contributions to updating the public health workforce through trainingAdele L Franks, Ross C Brownson, Carol Bryant, et al.
ACS Omega|October 13, 2025
Controlled Acceleration of Intaglio Ink Curing via Encapsulated AdditivesAllison F Moyer, Doug Trigg, Michael A Berkson, et al.
British Journal of Cancer|October 22, 2009
Lapatinib monotherapy in patients with relapsed, advanced, or metastatic breast cancer: efficacy, safety, and biomarker results from Japanese patients phase II studiesM Toi, H Iwata, Y Fujiwara, et al.
Pageof 35